×
ADVERTISEMENT

DECEMBER 16, 2020

Impact of Rapid Diagnostic Testing and Biomarkers on Antimicrobial Stewardship

Deriving Their Optimal Benefit

Karen Fong, PharmD, BCIDP, AAHIVP
Clinical Pharmacist
Infectious Diseases and Antimicrobial Stewardship
Department of Pharmacy
University of Utah Health
Salt Lake City, Utah

Rapid diagnostic tests (RDTs) represent an exciting advancement in the clinical microbiology laboratory, with the potential to transform the management of infectious diseases by allowing for more rapid and robust microbiological diagnoses.

These technological advances can guide early clinical decision making in the management of